Alison Cecily Finger - 28 Sep 2023 Form 3 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Alison C. Finger, by Brian Lenz as attorney-in-fact
Issuer symbol
ADMA
Transactions as of
28 Sep 2023
Net transactions value
$0
Form type
3
Filing time
02 Oct 2023, 16:46:39 UTC
Previous filing
25 Sep 2023
Next filing
28 Feb 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADMA Stock Option (Right to Buy) 28 Sep 2023 Common Stock 98,870 $3.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted to the reporting person on 09/28/2023 upon joining the ADMA Biologics, Inc. Board of Directors and will vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Remarks:

Exhibit 24 - Power of Attorney